PMV Capital Advisers’s Pfizer PFE Stock Holding History

PMV Capital Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$427	Buy	+15	New	+$399	﹤0.01%	67

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

PMV Capital Advisers's PFE Position: Q1 2026 in Review

PMV Capital Advisers opened a new position in Pfizer (PFE) in Q1 2026: 15 shares worth $427. The stake represents ﹤0.01% of the portfolio and ranks #67 among its holdings.

2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

PMV Capital Advisers held 15 shares of Pfizer worth $427 as of Q1 2026.
Pfizer was a new PMV Capital Advisers position in Q1 2026.
Pfizer made up ﹤0.01% of PMV Capital Advisers's portfolio in Q1 2026, its #67 holding.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on PMV Capital Advisers's 13F filing for Q1 2026, filed 16 Apr 2026.